BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8301510)

  • 1. Paratesticular neuroblastoma with N-myc activation.
    Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Enomoto H; Horie H; Shirasawa H; Simizu B
    J Pediatr Surg; 1993 Dec; 28(12):1612-4. PubMed ID: 8301510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
    Hiyama E; Hiyama K; Yokoyama T
    Cancer Res; 1991 Apr; 51(7):1946-51. PubMed ID: 2004381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
    Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive analysis for N-myc amplification in neuroblastoma based on fluorescence in situ hybridization.
    Tajiri T; Shono K; Fujii Y; Noguchi S; Kinoshita Y; Tsuneyoshi M; Suita S
    J Pediatr Surg; 1999 Nov; 34(11):1615-9. PubMed ID: 10591554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
    Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B
    Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-MYC overexpression and neuroblastomas.
    Kruidering M
    Trends Pharmacol Sci; 2002 Oct; 23(10):452. PubMed ID: 12368064
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
    Brack T; Scholz RB; Milde-Langosch K; Heinsohn S; Löning T; Kabisch H
    Cancer Detect Prev; 1992; 16(3):185-92. PubMed ID: 1458508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal neuroblastoma: biologic behavior and surgical aspects.
    Hiyama E; Yokoyama T; Hiyama K; Yamaoka H; Matsuura Y; Nishimura Si; Ueda K
    Cancer; 2000 Apr; 88(8):1955-63. PubMed ID: 10760774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal paratesticular neuroblastoma misdiagnosed as in utero torsion of testis.
    Calonge WM; Heitor F; Castro LP; Meruje M; Coutinho SP; Cunha C; Ochoa de Castro A
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):693-5. PubMed ID: 15454846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases.
    Tanaka T; Slamon DJ; Shimada H; Shimoda H; Fujisawa T; Ida N; Seeger RC
    Cancer; 1991 Sep; 68(6):1296-302. PubMed ID: 1873783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary paratesticular neuroblastoma: an important differential diagnosis.
    Berger M; Hurtado MF; Bertolez SP; Fernandez-Pineda I
    J Pediatr Urol; 2013 Apr; 9(2):e117-22. PubMed ID: 23142259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-myc gene amplification and other prognosis-associated factors in neuroblastoma.
    Hiyama E; Yokoyama T; Ichikawa T; Ishii T; Hiyama K
    J Pediatr Surg; 1990 Oct; 25(10):1095-9. PubMed ID: 2262866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of expression between N-myc gene and major histocompatibility complex class I gene in surgically resected human neuroblastoma.
    Sugio K; Nakagawara A; Sasazuki T
    Cancer; 1991 Mar; 67(5):1384-8. PubMed ID: 1991301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription of N-myc and proliferation-related genes is linked in human neuroblastoma.
    Raschellà G; Negroni A; Giubilei C; Romeo A; Ferrari S; Castello MA; Dominici C
    Cancer Lett; 1991 Jan; 56(1):45-51. PubMed ID: 2004353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital neuroblastoma presenting as a paratesticular tumor.
    Yamashina M; Kayan H; Katayama I; Shibuya A
    J Urol; 1988 Apr; 139(4):796-7. PubMed ID: 3352046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model.
    Norris MD; Burkhart CA; Marshall GM; Weiss WA; Haber M
    Med Pediatr Oncol; 2000 Dec; 35(6):585-9. PubMed ID: 11107123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [N-myc status of neuroblastoma from bone marrow cells].
    Brack T; Finckenstein FG; Kabisch H
    Klin Padiatr; 1991; 203(4):323-7. PubMed ID: 1942939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo karyotypic evolution with altered biological characteristics in a case of neuroblastoma.
    Enomoto H; Nakamura Y; Kondo K; Hirose M; Kaneko Y; Horie H; Takahashi H; Ohnuma N; Tanabe M; Nakagawara A
    J Pediatr Surg; 1998 Sep; 33(9):1404-7. PubMed ID: 9766365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cellular motility in the invasion of human neuroblastoma cells with or without N-myc amplification and expression.
    Zaizen Y; Taniguchi S; Suita S
    J Pediatr Surg; 1998 Dec; 33(12):1765-70. PubMed ID: 9869047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.